Scientists have restored the hearing of mice partly deafened by noise, using advanced tools to boost the production of a key protein in their ears.
By demonstrating the importance of the protein, called NT3, in maintaining communication between the ears and brain, these new findings pave the way for research in humans that could improve treatment of hearing loss caused by noise exposure and normal aging.
In a new paper in the online journal eLife, the team from the University of Michigan Medical School’s Kresge Hearing Research Institute and Harvard University report the results of their work to understand NT3’s role in the inner ear, and the impact of increased NT3 production on hearing after a noise exposure.
Their work also illustrates the key role of cells that have traditionally been seen as the “supporting actors” of the ear-brain connection. Called supporting cells, they form a physical base for the hearing system’s “stars”: the hair cells in the ear that interact directly with the nerves that carry sound signals to the brain. This new research identifies the critical role of these supporting cells along with the NT3 molecules that they produce.
NT3 is crucial to the body’s ability to form and maintain connections between hair cells and nerve cells, the researchers demonstrate. This special type of connection, called a ribbon synapse, allows extra-rapid communication of signals that travel back and forth across tiny gaps between the two types of cells.
“It has become apparent that hearing loss due to damaged ribbon synapses is a very common and challenging problem, whether it’s due to noise or normal aging,” says Gabriel Corfas, Ph.D., who led the team and directs the U-M institute. “We began this work 15 years ago to answer very basic questions about the inner ear, and now we have been able to restore hearing after partial deafening with noise, a common problem for people. It’s very exciting.”
Using a special genetic technique, the researchers made it possible for some mice to produce additional NT3 in cells of specific areas of the inner ear after they were exposed to noise loud enough to reduce hearing. Mice with extra NT3 regained their ability to hear much better than the control mice.
Now, says Corfas, his team will explore the role of NT3 in human ears, and seek drugs that might boost NT3 action or production. While the use of such drugs in humans could be several years away, the new discovery gives them a specific target to pursue.
The Latest on: Hearing loss
via Google News
The Latest on: Hearing loss
- Veterans look for relief from hearing loss in courton October 18, 2019 at 8:28 am
But the ones bought by the Defense Department from the 3M company didn’t work, according to the government, who says that has led to serious issues involving hearing loss. The earplugs in question are ...
- 'Hearing Aids Could Become As Common As Glasses' - More Than 1.1 Billion Young People Face Hearing Losson October 17, 2019 at 10:43 pm
We’ve had access to music and sound on-the-go for the better part of four decades now, and people are experiencing the effects. “Some studies have shown that cases of noise-induced hearing loss has ...
- Houston pediatric hearing loss organization to move to Texas Medical Center next yearon October 16, 2019 at 12:43 pm
The Center for Hearing and Speech, a resource for pediatric hearing loss that includes a school for young children, plans to move into its new location in the Texas Medical Center next fall. After ...
- We used smartphones to screen young children for vision and hearing losson October 14, 2019 at 5:51 am
But more than 90% of children with hearing or vision loss live in low and middle-income countries where services to detect problems early are unavailable. Called invisible disabilities hearing and ...
- Schoharie County girl's lemon(aide) you can't drink helps kids who have hearing losson October 11, 2019 at 4:32 pm
She's making lemons - or as she calls them – "Lemon(aids)," which she sells to help kids like her sisters. When Molly, the youngest of three girls, was born with hearing loss, the family started ...
- Frequency Therapeutics Commences Dosing in its Phase 2a Study of FX-322 for Sensorineural Hearing Loss; FDA Grants FX-322 Fast Track Designationon October 10, 2019 at 5:05 pm
FX-322 is being developed for the treatment of sensorineural hearing loss (SNHL), the most common type of hearing loss. The company also announced today that the U.S. Food and Drug Administration (FDA ...
- Frequency Therapeutics launches mid-stage study of hearing loss candidate FX-322on October 10, 2019 at 12:27 pm
Dosing is underway in a Phase 2a clinical trial evaluating Frequency Therapeutics' (FREQ +1.5%) lead candidate FX-322 in patients with stable sensorineural hearing loss (SNHL) (the most common type).
- Dr. Leslie Soiles & Tina Soika - Breaking Down the Stigma of Hearing Losson October 10, 2019 at 12:02 pm
It’s an often-misunderstood condition that impacts an estimated 48 million Americans. We’re talking about hearing loss. To help us learn more about it were Dr. Leslie Soy-less and Tina Soy-ka from ...
- Local couple helping people in poor countries with hearing losson October 7, 2019 at 3:51 pm
(KMOV.com) – The owners of Southwestern Hearing Centers just got from Peru, where they volunteered to help fit people with hearing aids.
- Does Hearing Loss Cause Dementia?on October 7, 2019 at 11:19 am
‘Hearing loss causes dementia.’ These are sobering words, especially for the Deaf and hard of hearing community. As someone who is hard of hearing and is choosing not to wear hearing aids, these words ...
via Bing News